May 11, 2010
The FDA's Division of Drug Marketing, Advertising, and Communications (DDMAC) has launched the Bad Ad Program, designed to educate healthcare providers about their role in ensuring that prescription drug advertising and promotion is truthful, and not misleading.
January 07, 2010
Sciele Pharma announced the availability of Adrenaclick (epinephrine injection auto-injector) for the emergency treatment of severe allergic reactions (Type I).
October 26, 2009
DEY Pharma has launched re-designed EpiPen and EpiPen Jr. Auto-Injectors (epinephrine [1:1000]) that feature needle-protection, for no exposed needle, before and after use.
September 16, 2009
The FDA has notified healthcare professionals that a Boxed Warning is being added to the prescribing information for promethazine hydrochloride products, describing the risks of severe tissue injury, including gangrene, requiring amputation following intravenous administration of promethazine.
September 09, 2010
The FDA is requiring that gadolinium-based contrast agents (GBCAs) carry new warnings on their labels about the risk of nephrogenic systemic fibrosis (NSF), a rare and potentially fatal condition, if the drug is administered to certain patients with kidney disease.